Steven J. Kittner

Learn More
on behalf of the American Heart Association Statistics Committee and Stroke Statistics Nathan D. Wong, Daniel Woo and Melanie B. Turner Elsayed Z. Soliman, Paul D. Sorlie, Nona Sotoodehnia, Tanya N. Turan, Salim S. Virani, Claudia S. Moy, Dariush Mozaffarian, Michael E. Mussolino, Graham Nichol, Nina P. Paynter, Lynda D. Lisabeth, Diane M. Makuc, Gregory M.(More)
Donald Lloyd-Jones, MD, ScM, FAHA; Robert Adams, MD, FAHA; Mercedes Carnethon, PhD, FAHA; Giovanni De Simone, MD; T. Bruce Ferguson, MD; Katherine Flegal, PhD*; Earl Ford, MD, MPH*; Karen Furie, MD; Alan Go, MD; Kurt Greenlund, PhD*; Nancy Haase; Susan Hailpern, DPH; Michael Ho, MD, PhD; Virginia Howard, PhD, FAHA; Brett Kissela, MD; Steven Kittner, MD;(More)
on behalf of the American Heart Association Statistics Committee and Stroke Statistics Virani, Nathan D. Wong, Daniel Woo and Melanie B. Turner Nina P. Paynter, Pamela J. Schreiner, Paul D. Sorlie, Joel Stein, Tanya N. Turan, Salim S. Darren K. McGuire, Emile R. Mohler, Claudia S. Moy, Michael E. Mussolino, Graham Nichol, Lynda D. Lisabeth, David Magid,(More)
Donald Lloyd-Jones, MD, ScM, FAHA; Robert J. Adams, MD, FAHA; Todd M. Brown, MD; Mercedes Carnethon, PhD, FAHA; Shifan Dai, MD, PhD*; Giovanni De Simone, MD; T. Bruce Ferguson, MD; Earl Ford, MD, MPH*; Karen Furie, MD; Cathleen Gillespie; Alan Go, MD; Kurt Greenlund, PhD*; Nancy Haase; Susan Hailpern, DPH; P. Michael Ho, MD, PhD; Virginia Howard, PhD, FAHA;(More)
WRITING GROUP MEMBERS Véronique L. Roger, MD, MPH, FAHA; Alan S. Go, MD; Donald M. Lloyd-Jones, MD, ScM, FAHA; Emelia J. Benjamin, MD, ScM, FAHA; Jarett D. Berry, MD; William B. Borden, MD; Dawn M. Bravata, MD; Shifan Dai, MD, PhD*; Earl S. Ford, MD, MPH, FAHA*; Caroline S. Fox, MD, MPH; Heather J. Fullerton, MD; Cathleen Gillespie, MS*; Susan M. Hailpern,(More)
The aim of this updated guideline is to provide comprehensive and timely evidence-based recommendations on the prevention of future stroke among survivors of ischemic stroke or transient ischemic attack. The guideline is addressed to all clinicians who manage secondary prevention for these patients. Evidence-based recommendations are provided for control of(More)